Clinical Trials Browser

Leukemia, Myeloid, Acute × regorafenib × 90 days × Clear all

NCT03042689 2026-01-08

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute